GDTC icon

CytoMed Therapeutics
GDTC

5 hedge funds and large institutions have $70.8K invested in CytoMed Therapeutics in 2025 Q4 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more capital invested

Capital invested by funds: $ → $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
5
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$57.8K
2
+$23K
3
+$20.1K
4
Osaic Holdings
Osaic Holdings
Arizona
+$41

Top Sellers

1
-$23.7K
2
-$9.62K
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$39.7K
TSS
2
Two Sigma Securities
New York
$15.8K
SG
3
StoneX Group
New York
$13.8K
UBS Group
4
UBS Group
Switzerland
$1.42K
Osaic Holdings
5
Osaic Holdings
Arizona
$28
WANY
6
Wealthspire Advisors (New York)
New York
–